Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. - Wikidata - wikimedia - TriplyDB

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

http://www.wikidata.org/entity/Q41724594

about

Opioid agonist treatment for pharmaceutical opioid dependent people Methadone at tapered doses for the management of opioid withdrawal Oral substitution treatment of injecting opioid users for prevention of HIV infection Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence Substitution treatment of injecting opioid users for prevention of HIV infection Methadone at tapered doses for the management of opioid withdrawal Dihydrocodeine for detoxification and maintenance treatment in illicit opiate-dependent individuals Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria Drug dependence, parenting responsibilities, and treatment history: why doesn't mom go for help?A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention Structural-level factors affecting implementation of the methadone maintenance therapy program in China.A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.New methods of treatment efficacy research: bridging clinical research and clinical practice.Buprenorphine treatment in an urban community health center: what to expect Psychometric properties of the Chinese craving beliefs questionnaire for heroin abusers in methadone treatment.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Problems for clinical judgement: 5. Principles of influence in medical practice Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse.Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patients Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.Methadone treatment providers' views of drug court policy and practice: a case study of New York State Standard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy The impact of financial discharge from methadone maintenance therapy on incarceration Opioid dependence treatment, including buprenorphine/naloxone.The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.Characteristics and 9-month outcomes of discharged methadone maintenance clients.Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.Methadone medical maintenance in primary care. An implementation evaluation.Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: a realist synthesis of what makes interventions work.Policy progress for physician treatment of opiate addiction.Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan Narcotic-induced hypogonadism during therapy for heroin addiction.Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependent adults: a randomized controlled trial.Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment Commentary on Burns et al. (2015): retention in buprenorphine treatment Supply of buprenorphine waivered physicians: the influence of state policies.

P2860

Q24185775-86FE47D5-7DA5-4907-A16F-0BC5D31C5AEB Q24200729-6DD4E5BF-C562-4B2A-8029-1978A06F87A4 Q24234956-BF5082B6-4605-46BA-99EB-E830F51EC2F0 Q24239965-8C1D1AAD-A412-48A0-952F-7A1DD803934C Q24243272-8345CB58-146D-4DAF-87D2-7073C2C2F5B3 Q24246574-F5BA5010-51E6-492D-9EA4-239398F00A8E Q26471618-00B07C3E-8CD3-42EB-BE57-60EFC8E0E0CD Q26778626-23366277-674F-48DE-AD0F-90651BB4D643 Q28344318-60AD7635-4D6A-4DE3-8530-E85A27B33FBF Q28655452-30B5FD15-31EF-450C-8085-8E80F2817844 Q33624370-98914E03-763A-4B94-8962-0A3574B472EA Q33651514-18592047-594C-4DFF-874B-4BCB8F30B21A Q33669425-9947B829-5C43-4BD7-B56F-D5B119B4A916 Q33735289-78BD15BA-EDBB-4CC3-A6DE-14913BAA649F Q33841448-AD56B608-549B-4ABF-B050-D291A927255A Q33870389-58C55A62-8CA5-4B91-AA4D-B17808798514 Q33870799-30CE16CE-A4BD-4DFA-852D-B31A01D13B9A Q33943801-FE859E2E-96F7-4889-BF57-4D55404E16D3 Q34051233-42EBBDA7-3894-4F9F-B0B1-136EE3165EC3 Q34081656-592D4A4A-931B-461B-B569-5F85E65B20A9 Q34113771-B424F705-81CC-4259-AFD4-05B8E18C41F8 Q34216585-8CB7DD68-A89D-45EA-8B47-DA82EBA21D68 Q34250149-7F5FBC5D-8203-4A86-A3AE-3B70E83F9BEE Q34437363-760EEF03-1796-4CB9-9198-90B65A559619 Q34472876-24D81AC5-A623-44DA-A0D8-8912F6F75633 Q34481998-D094F2A8-B367-45DD-A730-991D9B802711 Q34527971-E85F7033-00B3-421B-8AFC-8CF99FDA077A Q34533873-1F282CB6-EE29-4CC5-8A56-9DD6E993AEB6 Q34620483-F5BB56AA-0379-4080-908A-C7ACFFCE5AEF Q34674269-45546A32-61BA-4752-90F8-6FD45E7C4696 Q34704122-7428799A-47DE-4DB3-9AA0-14579B2F079B Q34722914-E94D7F55-5113-43B9-991A-B850F23A5C30 Q34728976-0B0C62AB-1261-41D7-84E9-AB8D6CB79142 Q34743036-15076F1B-3186-4C11-879C-C44318429955 Q34818254-5B88C07E-2144-49D6-B9AF-04693D502663 Q34893324-4CD55B59-183C-48F0-8561-21E7853C8B0A Q35023989-5BCBAFA5-58D2-427F-9D97-301634BA5EBA Q35074748-2587D6A1-10B9-4D46-A1D1-87524859C8E3 Q35198995-DBFBB794-0FBE-47A6-B910-E54E40C4332B Q35571613-3CE2A6CB-D63F-42F4-BD2B-0D5046200578

P2860

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

http://www.wikidata.org/entity/Q41724594

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Methadone maintenance vs 180-d ...... a randomized controlled trial.

@en

type

label

Methadone maintenance vs 180-d ...... a randomized controlled trial.

@en

prefLabel

Methadone maintenance vs 180-d ...... a randomized controlled trial.

@en

P1433

Q41724594-B7F8D003-E02D-4975-BEE0-1ADBF2263666

P1476

Q41724594-FB5AAF42-E292-443E-8BB1-F7FAA54018C7

P2093

Q41724594-0AE37AE8-2753-47E0-889D-574580739209

Q41724594-4F3CD1C2-27EC-4E5B-9C8F-F02794F23A4C

Q41724594-8D60E855-F73E-46A6-BF20-E6F122C8F51C

Q41724594-9477A33E-6A85-4905-ABDD-3CD54EE71BD8

Q41724594-B386510A-754C-4069-89E0-D0917A97052C

Q41724594-C2B804BD-51AA-4387-BF00-8D3B9D9380FE

Q41724594-D3E8FADB-7AA4-4BF6-897C-4698177FD8B5

Q41724594-D8AEA44D-0E10-4F5C-968D-0F2FF667691D

P304

Q41724594-D78F6B8F-4CB5-4714-8F4C-0EC29C9C1995

P31

Q41724594-F96426F8-D657-462D-A522-A0F710D5C9C3

P356

Q41724594-9EE95F7E-D919-4B3A-974D-DBACD6BBDAA1

P407

Q41724594-39D07AB5-3F67-4600-A87E-C83130961CE0

P433

Q41724594-ED285278-EF37-4126-9771-EA62653FE081

P478

Q41724594-638AD714-7155-40D0-B130-83B2E74D9958

P577

Q41724594-0680F9D3-63AB-485A-85A9-63281CF5200F

P5875

Q41724594-5EB2669E-F503-4D3D-9B8A-BFD24E30420D

P698

Q41724594-F6F13A15-61C0-4CC6-98A9-CFB070D33FF0

P356

JAMA.283.10.1303

P1433

Journal of the American Medical Association

P1476

Methadone maintenance vs 180-d ...... a randomized controlled trial.

@en

P2093

A Rosen

http://www.w3.org/2001/XMLSchema#string

C Masson

http://www.w3.org/2001/XMLSchema#string

H Robillard

http://www.w3.org/2001/XMLSchema#string

H W Clark

http://www.w3.org/2001/XMLSchema#string

K L Delucchi

http://www.w3.org/2001/XMLSchema#string

K L Sees

http://www.w3.org/2001/XMLSchema#string

P Banys

http://www.w3.org/2001/XMLSchema#string

S M Hall

http://www.w3.org/2001/XMLSchema#string

P304

1303-1310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.283.10.1303

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P577

2000-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12600589

http://www.w3.org/2001/XMLSchema#string

P698

10714729

http://www.w3.org/2001/XMLSchema#string